BRIOCOLD oral susp: montelukast 4 mg, levocetirizine dihydrochloride 2.5 mg/5 mL.
R03DC53 - montelukast, combinations ; Belongs to the class of leukotriene receptor antagonists. Used in the systemic treatment of obstructive airway diseases.
BRIOCOLD oral susp
30ml (54 INR)